Navigation Links
CVS Caremark Corporation Announces Quarterly Dividend
Date:3/4/2009

WOONSOCKET, R.I., March 4 /PRNewswire-FirstCall/ -- CVS Caremark Corporation (NYSE: CVS) today announced that its Board of Directors has approved its quarterly dividend of $0.07625 per share on the Common Stock of the Corporation, payable May 4, 2009 to holders of record on April 22, 2009.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090226/NE75914LOGO )

About CVS Caremark

CVS Caremark is the largest provider of prescriptions in the nation. The Company fills or manages more than 1 billion prescriptions annually. Through its unmatched breadth of service offerings, CVS Caremark is transforming the delivery of health care services in the U.S. The Company is uniquely positioned to effectively manage costs and improve health care outcomes through its more than 6,900 CVS/pharmacy and Longs Drugs stores; its Caremark Pharmacy Services division (pharmacy benefit management, mail order and specialty pharmacy); its retail-based health clinic subsidiary, MinuteClinic; and its online pharmacy, CVS.com. General information about CVS Caremark is available through the Investors section of the Company's Web site, at cvscaremark.com, as well as through the Newsroom section of the Company's Web site, at cvscaremark.com/newsroom.


'/>"/>
SOURCE CVS Caremark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. CVS Caremark Health Management Programs Help Multiple Sclerosis Patients Better Manage Weight Issues and Improve BMI
2. CVS Caremark Corporation to Present at the Raymond James Institutional Investors Conference on March 10th
3. CVS Caremark Reports Record Results in Fourth Quarter and Year 2008
4. CVS Caremark Issues Statement on Settlement Concerning Disposal of Patient Information at its Retail Stores
5. Caremark Customer Care Centers Recognized for Customer Satisfaction Excellence by J.D. Power and Associates Certified Call Center Program(SM)
6. CVS Caremark Presents Influenza Vaccine Data at Rescheduled 2008 DMAA Annual Meeting
7. CVS Caremark Named Finalist in URAC Annual Best Practices in Health Care Consumer Empowerment and Protection Awards
8. CVS Caremark Applauds FTCs Leadership on Follow-on Biologics
9. CVS Caremark All Kids Can Announces the Opening of a Boundless Playground in Los Angeles to Serve Children of All Abilities
10. CVS Caremark Names Troyen Brennan, MD, EVP, Chief Medical Officer
11. SilverScript Insurance Company, a CVS Caremark Company, Provides Variety of Medicare Prescription Drug Plan Options for 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... Experts from the ... AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes Convention Center in ... topics including advance care planning, healthcare costs and patient and family engagement. , ...
(Date:6/25/2016)... ... ... Bruton Memorial Library on June 21 due to a possible lice infestation, as reported by ... lice: the parasite’s ability to live away from a human host, and to infest common ... the event that lice have simply gotten out of control. , As lice are a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... First ... United States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell ... facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin ... injury. Recently, he has implemented orthobiologic procedures as a method for treating his ... of the first doctors to perform the treatment. Orthobiologics are substances that orthopaedic ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits ... terms of the latter, setting the bar too high can result in disappointment, perhaps ... slow progress toward their goal. , Research from PsychTests.com reveals that ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... India , June 24, 2016 ... Needles Market by Type (Standard Pen Needles, Safety Pen ... Therapy (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, ... by MarketsandMarkets, This report studies the market for the ... expected to reach USD 2.81 Billion by 2021 from ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, a ... invasive and more durable cerebrospinal fluid treatments, today ... The Series-A funding is led by Innova Memphis, ... and other private investors.  Arkis, new financing will ... and the market release of its in-licensed Endexo® ...
(Date:6/23/2016)... 2016 Any dentist who has made an implant ... process. Many of them do not even offer this as ... high laboratory costs involved. And those who ARE able to ... a high cost that the majority of today,s patients would ... Parsa Zadeh , founder of Dental Evolutions Inc. and inventor ...
Breaking Medicine Technology: